556 related articles for article (PubMed ID: 31467670)
21. Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli.
Zhao S; Wu Y; Dai Z; Chen Y; Zhou X; Zhao J
Eur J Clin Microbiol Infect Dis; 2022 May; 41(5):713-721. PubMed ID: 35190911
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand.
Anunnatsiri S; Towiwat P; Chaimanee P
Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1169-77. PubMed ID: 23431823
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli.
Haruki Y; Hagiya H; Haruki M; Sugiyama T
J Infect Chemother; 2018 Nov; 24(11):944-947. PubMed ID: 29803763
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
25. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
26. Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Liu M; Li M; Wu L; Song Q; Zhao D; Chen Z; Kang M; Xie Y
Medicine (Baltimore); 2018 Sep; 97(38):e12445. PubMed ID: 30235729
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Park SY; Kang CI; Joo EJ; Ha YE; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454
[TBL] [Abstract][Full Text] [Related]
28. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
Joo EJ; Park DA; Lee NR; Moon SY; Choi JK; Ko JH; Peck KR
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2093-2100. PubMed ID: 28643188
[TBL] [Abstract][Full Text] [Related]
29. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.
Chung HC; Lai CH; Lin JN; Huang CK; Liang SH; Chen WF; Shih YC; Lin HH; Wang JL
Antimicrob Agents Chemother; 2012 Feb; 56(2):618-22. PubMed ID: 22123694
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing
Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N
Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616
[No Abstract] [Full Text] [Related]
31. Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
Namikawa H; Yamada K; Fujimoto H; Oinuma KI; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
Intern Med; 2017; 56(14):1807-1815. PubMed ID: 28717075
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department.
Lee H; Han SB; Kim JH; Kang S; Durey A
Am J Emerg Med; 2018 Sep; 36(9):1608-1612. PubMed ID: 29373168
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Kang CI; Cheong HS; Chung DR; Peck KR; Song JH; Oh MD; Choe KW
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):85-8. PubMed ID: 17943331
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
[TBL] [Abstract][Full Text] [Related]
36. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing
Park SY; Kang CI; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Korean J Intern Med; 2017 Jan; 32(1):146-157. PubMed ID: 27093979
[TBL] [Abstract][Full Text] [Related]
38. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J
J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822
[TBL] [Abstract][Full Text] [Related]
39. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
[TBL] [Abstract][Full Text] [Related]
40. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
